Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
30%

OVERLAP
BY WEIGHT
17

# OF OVERLAPPING
HOLDINGS
PBE
28
HOLDINGS
61%
ALSO IN BBP
BBP
65
HOLDINGS
28%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBP)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in BBP
Overlap
GILEAD SCIENCES INC 4.9% 2.1% 2.1%
HALOZYME THERAPEUTICS INC 2.5% 2.1% 2.1%
TG THERAPEUTICS INC 2.8% 2.1% 2.1%
AMGEN INC 4.8% 2.0% 2.0%
PTC THERAPEUTICS INC 2.8% 1.8% 1.8%
PBE Overweight Relative to BBP
ILLUMINA INC 5.6%
ROYALTY PHARMA PLC CLASS A 5.3%
ALNYLAM PHARMACEUTICALS INC 3.8%
ANAVEX LIFE SCIENCES CORP. 3.4%
PROTAGONIST THERAPEUTICS, INC. 3.2%
VERTEX PHARMACEUTICALS INC 3.1%
UNITED THERAPEUTICS CORP 3.0%
CAREDX, INC. 2.9%
AMGEN INC 2.9%
BIOMARIN PHARMACEUTICAL INC 2.8%
PBE Underweight Relative to BBP
INTRA-CELLULAR THERAPIES INC -2.6%
BEIGENE LTD. SPONSORED ADR -2.3%
ZAI LAB LTD. UNSPONSORED ADR -2.2%
SAGE THERAPEUTICS INC -2.2%
AXSOME THERAPEUTICS, INC. -2.1%
SPRINGWORKS THERAPEUTICS, INC. -2.1%
BRIDGEBIO PHARMA, INC. -1.9%
ASCENDIS PHARMA A/S -1.8%
MADRIGAL PHARMACEUTICALS, INC. -1.8%
HARMONY BIOSCIENCES HOLDINGS, INC. -1.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY